MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts

http://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_apac_analysis_market_forecasts.html

MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts

Summary

Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions.

Countries in the Asia Pacific (APAC) region such as Japan and China and the South American country of Brazil will have growth rates that are more than double the global CAGR. This is primarily due to the increased market access of each country's population to healthcare resources and the increased adoption of more expensive core needle biopsy devices over fine needle aspiration devices.

Scope

- An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized APAC biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019.
- Investigation of current and future market competition for biopsy devices.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the biopsy devices sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL).

Reasons to buy

- Understand the trends shaping and driving APAC biopsy devices Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in APAC biopsy devices market through 2019.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in APAC biopsy devices market landscape? Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 14
2.1 Overview 14
2.2 Catalyst 14
2.3 Related Reports 15
3 Industry Overview 16
3.1 Types of Biopsies 16
3.1.1 Surgical Biopsy 16
3.1.2 Fine Needle Aspiration 16
3.1.3 Core Needle Biopsy 17
3.1.4 Vacuum-Assisted Biopsy 17
3.2 Biopsy Procedure Trends 18
3.2.1 Asia-Pacific Region 18
3.3 Market Access to Cancer Screening Programs 23
3.3.1 Regulation 23
3.3.2 Biopsy Device Adoption Patterns 26
3.3.3 Reimbursement Trends 30
3.4 Regulatory Issues/Recalls 32
3.5 Mergers & Acquisitions/Key Partnerships 33
3.5.1 Hologic Acquires Suros Surgical Systems 33
3.5.2 C. R. Bard Acquires SenoRx 33
3.5.3 Devicor Medical Products Acquires Breast Care Portfolio from Ethicon Endo-Surgery 33
3.6 Economic Impact of Cancer Screening and Treatment 34
3.7 Additional Indications for Biopsy Devices 35
4 Unmet Needs 36
4.1 Overview 36
4.2 More Efficient Screening Tests for Prostate Cancer 36
4.3 More Efficient Screening Tests for Breast Cancer 37
4.4 More Efficient Screening Guidelines for Thyroid Cancer 37
4.5 Screening Tests That Can Provide Histological Analysis In Situ 38
5 Market Opportunity Analysis 39
5.1 Increase Marketing for Vacuum-Assisted Biopsy Devices in European Countries 39
5.2 Bundling Solutions 40
5.3 Focus Efforts on China's Increasing Adoption of VAB Devices 41
5.4 Market for Prostate Cancer Screening Coverage in Europe 41
6 Market Drivers and Barriers 43
6.1 Market Drivers 43
6.1.1 Inadequate Screening Tests for Particular Cancers 43
6.1.2 Demand for Minimally-Invasive Biopsy Techniques 44
6.1.3 Increased Adherence to Certain Cancer Screening Guidelines 44
6.1.4 Aging Patient Population 45
6.2 Market Barriers 46
6.2.1 Increased Competition from Other Cancer Diagnostic Tests 46
6.2.2 Breast Biopsy Reimbursement Bundling 49
6.2.3 Decreased Adherence to Certain Cancer Screening Guidelines 51
6.2.4 Benefits of Mass Prostate Cancer Screening Being Outweighed by Risks 52
7 Competitive Assessment 53
7.1 Overview 53
7.2 Classification Based on System 53
7.2.1 Vacuum-Assisted Biopsy Devices 53
7.2.2 Core Needle Biopsy Devices 55
7.2.3 Fine Needle Aspiration Devices 56
8 Pipeline Assessment 57
8.1 Overview 57
8.1.1 Optical Biopsy 57
8.1.2 Liquid Biopsy 58
9 Clinical Trial Analysis 60
10 Current and Future Players 62
10.1 Trends in Corporate Strategy 62
10.2 Company Profiles 62
10.2.1 Argon Medical Devices 62
10.2.2 Boston Scientific 65
10.2.3 Cardinal Health 68
10.2.4 CareFusion Corporation 69
10.2.5 Cook Medical 71
10.2.6 C. R. Bard 74
10.2.7 Devicor Medical Products 80
10.2.8 DTR Medical 84
10.2.9 Gallini Medical Devices 86
10.2.10 Hologic 88
10.2.11 INRAD 91
10.2.12 Intact Medical Corporation 93
10.2.13 TSK Laboratory 94
11 Market Outlook 97
11.1 Company Market Share 97
11.1.1 Vacuum-Assisted Biopsy Market Share 97
11.1.2 Core Needle Biopsy/Fine Needle Aspiration Market Share 98
11.2 By Segment 100
11.2.1 Fine Needle Aspiration 100
11.2.2 Core Needle Biopsy 101
11.2.3 Vacuum-Assisted Biopsy 102
11.3 By Geography 103
11.3.1 Japan 103
11.3.2 China 104
11.3.3 India 106
12 Appendix 108
12.1 Bibliography 108
12.2 Abbreviations 117
12.3 Report Methodology 119
12.3.1 Overview 119
12.3.2 Coverage 119
12.3.3 Primary Research 119
12.3.4 Secondary Research 120
12.3.5 Forecasting Methodology 121
12.4 Key Opinion Leaders Included in This Study 121
12.5 About the Authors 122
12.5.1 Joseph A. Gregory, Analyst, Surgical Devices 122
12.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 122
12.6 Global Head of Healthcare 123
12.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 123
12.7 About MediPoint 124
12.8 About GlobalData 124
12.9 Disclaimer 124

List of Tables

Table 1: Biopsy Device Adoption Patterns in Diagnosing Prostate Cancer, Global, 2013 and 2019 27
Table 2: Biopsy Device Adoption Patterns in Diagnosing Breast Cancer, Global, 2013 and 2019 28
Table 3: Biopsy Device Adoption Patterns in Diagnosing Lung Cancer, Global, 2013 and 2019 29
Table 4: Biopsy Device Adoption Patterns in Diagnosing Liver Cancer, Global, 2013 and 2019 29
Table 5: Biopsy Device Adoption Patterns in Diagnosing Thyroid Cancer, Global, 2013 and 2019 30
Table 6: Age Demographics, Age >65 Years, Global, 2013 45
Table 7: Stereotactic Breast Biopsy Ambulatory Surgery Center Billing, 2011 50
Table 8: Stereotactic Breast Biopsy Physician Billing, 2011 50
Table 9: Company Profile - Argon Medical Devices 63
Table 10: Product Portfolio - Argon Medical Devices 64
Table 11: Argon Medical Devices, SWOT Analysis, 2013 65
Table 12: Company Profile - Boston Scientific 66
Table 13: Product Portfolio - Boston Scientific 67
Table 14: Boston Scientific SWOT Analysis, 2013 67
Table 15: Company Profile - Cardinal Health 68
Table 16: Product Portfolio - Cardinal Health 69
Table 17: Cardinal Health SWOT Analysis, 2013 69
Table 18: Company Profile - CareFusion Corporation 70
Table 19: Product Portfolio - CareFusion 71
Table 20: CareFusion, SWOT Analysis, 2013 71
Table 21: Company Profile - Cook Medical 72
Table 22: Product Portfolio - Cook Medical 73
Table 23: Cook Medical, SWOT Analysis, 2013 74
Table 24: Company Profile - C. R. Bard 75
Table 25: Product Portfolio - C. R. Bard 75
Table 26: C.R. Bard, SWOT Analysis, 2013 79
Table 27: Company Profile - Devicor Medical Products 80
Table 28: Product Portfolio - Devicor Medical Products 83
Table 29: Devicor Medical Products SWOT Analysis, 2013 84
Table 30: Company Profile - DTR Medical 84
Table 31: Product Portfolio - DTR Medical 85
Table 32: DTR Medical SWOT Analysis, 2013 85
Table 33: Company Profile - Gallini Medical Devices 86
Table 34: Product Portfolio - Gallini Medical Devices 87
Table 35: Gallini Medical Devices SWOT Analysis, 2013 88
Table 36: Company Profile - Hologic 89
Table 37: Product Portfolio - Hologic 90
Table 38: Hologic SWOT Analysis, 2013 90
Table 39: Company Profile - INRAD 91
Table 40: Product Portfolio - INRAD 92
Table 41: INRAD SWOT Analysis, 2013 92
Table 42: Company Profile - Intact Medical Corporation 93
Table 43: Product Portfolio - Intact Medical Corporation 94
Table 44: Intact Medical Corporation SWOT Analysis, 2013 94
Table 45: Company Profile - TSK Laboratory 95
Table 46: Product Portfolio - TSK Laboratory 95
Table 47: TSK Laboratory SWOT Analysis, 2013 96
Table 48: VAB, Global Market Share, 2013 98
Table 49: CNB/FNA, Global Market Share, 2013 99
Table 50: APAC FNA Device Sales ($m) Forecast, 2010-2019 100
Table 51: APAC CNB Device Sales ($m) Forecast, 2010-2019 101
Table 52: APAC VAB Device Sales ($m) Forecast, 2010-2019 102
Table 53: Japan Biopsy Devices Sales ($m) Forecast, 2010-2019 103
Table 54: China Biopsy Devices Sales ($m) Forecast, 2010-2019 105
Table 55: India Biopsy Devices Sales ($m) Forecast, 2010-2019 106

List of Figures

Figure 1: Biopsy Procedure Volumes: Prostate, APAC Region, 2010-2019 19
Figure 2: Biopsy Procedure Volumes: Breast, APAC Region, 2010-2019 20
Figure 3: Biopsy Procedure Volumes: Lung, APAC Region, 2010-2019 21
Figure 4: Biopsy Procedure Volumes: Liver, APAC Region, 2010-2019 22
Figure 5: Biopsy Procedure Volumes: Thyroid, APAC Region, 2010-2019 23
Figure 6: CNB/FNA, Global Market Share, 2013 64
Figure 7: EnCor Breast Biopsy System 76
Figure 8: EnCor Enspire Breast Biopsy System 77
Figure 9: EnCor Ultra Breast Biopsy System 77
Figure 10: Finesse Ultra Breast Biopsy System 78
Figure 11: Vacora Breast Biopsy System 79
Figure 12: Original Mammotome System 81
Figure 13: Mammotome Elite 82
Figure 14: Mammotome Revolve 83
Figure 15: VAB, Global Market Share, 2013 98
Figure 16: CNB/FNA, Global Market Share, 2013 99
Figure 17: APAC FNA Device Sales ($m) Forecast, 2010-2019 100
Figure 18: APAC CNB Device Sales ($m) Forecast, 2010-2019 101
Figure 19: APAC VAB Device Sales ($m) Forecast, 2010-2019 102
Figure 20: Japan Biopsy Devices Sales ($) Forecast, 2010-2019 104
Figure 21: China Biopsy Devices Sales ($) Forecast, 2010-2019 105
Figure 22: India Biopsy Devices Sales ($) Forecast, 2010-2019 107

Read the full report:
MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts

http://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_apac_analysis_market_forecasts.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer



RELATED LINKS
http://www.reportbuyer.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.